4//SEC Filing
MYERS ROBERT L 4
Accession 0001179110-21-008909
CIK 0001446159other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:07 PM ET
Size
9.0 KB
Accession
0001179110-21-008909
Insider Transaction Report
Form 4
MYERS ROBERT L
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock, $.01 par value
2021-09-23$1.13/sh+33,334$37,667→ 33,411 total - Exercise/Conversion
Restricted Stock Units
2021-09-23−33,334→ 66,666 total→ Common Stock (33,334 underlying) - Disposition to Issuer
Common Stock, $.01 par value
2021-09-23$1.13/sh−10,200$11,526→ 23,211 total
Footnotes (3)
- [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
- [F2]On September 23, 2020, the reporting person was granted 100,000 restricted stock units, vesting in three annual installments beginning on the first anniversary of the grant date. The first of these installments vests on September 23, 2021. The remainder vests on each of 9/23/2022 and 9/23/2023.
- [F3]10,200 shares of common stock forfeited to Company on September 23, 2021 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.
Documents
Issuer
Predictive Oncology Inc.
CIK 0001446159
Entity typeother
Related Parties
1- filerCIK 0001553600
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:07 PM ET
- Size
- 9.0 KB